2 most recent filings and news items mentioning CABA. Updated every 60 seconds.
curl "https://api.brieftape.com/v1/tickers/CABA/news?limit=20"
Pull CABA filings straight into your trading bot, model, or app.
Get an API key — free tier: 10,000 calls/dayCabaletta Bio modified its capital structure to authorize 593.6M voting common shares, 6.4M non-voting common shares, and 10M preferred shares. The amendment enables the company to issue non-voting equity while preserving voting control for existing shareholders.
View filing at SEC.gov →Cabaletta announced encouraging Phase 1/2 clinical data for rese-cel across dermatomyositis, systemic sclerosis, and lupus, with 83% of dermatomyositis patients meeting registrational endpoints and maintaining responses off immunomodulators. The company plans to initiate systemic
View filing at SEC.gov →